These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

479 related items for PubMed ID: 7688112

  • 1. [Reliability and use of prostate-specific antigen in the management of patients with prostatic cancer].
    Hübler J, Jávor A.
    Orv Hetil; 1993 Jul 11; 134(28):1529-32. PubMed ID: 7688112
    [Abstract] [Full Text] [Related]

  • 2. [Clinical significance of prostate-specific antigen].
    Tveter KJ, Otnes B.
    Tidsskr Nor Laegeforen; 1994 Jan 20; 114(2):160-2. PubMed ID: 7510073
    [Abstract] [Full Text] [Related]

  • 3. [Prostate-specific antigen as a tumor marker of prostate carcinoma].
    Wymenga LF, Mensink HJ.
    Ned Tijdschr Geneeskd; 1999 Aug 21; 143(34):1733-8. PubMed ID: 10494319
    [Abstract] [Full Text] [Related]

  • 4. [Clinical evaluation of prostate antigen (PA) in prostate cancer].
    Kuriyama M.
    Gan No Rinsho; 1985 May 21; 31(6 Suppl):606-10. PubMed ID: 2411962
    [Abstract] [Full Text] [Related]

  • 5. [Prostatic specific antigen in the serum in prostatic cancer].
    Fuse H, Akakura K, Akimoto S, Shimazaki J.
    Hinyokika Kiyo; 1987 Jul 21; 33(7):1049-53. PubMed ID: 2446484
    [Abstract] [Full Text] [Related]

  • 6. Pre-analytical and biological variability of prostatic acid phosphatase and prostate-specific antigen in serum from patients with prostatic pathology.
    Panteghini M, Pagani F, Bonora R.
    Eur J Clin Chem Clin Biochem; 1992 Mar 21; 30(3):135-9. PubMed ID: 1376155
    [Abstract] [Full Text] [Related]

  • 7. Highly specific detection of prostate-specific antigen-positive cells in the blood of patients with prostate cancer or benign prostatic hyperplasia, using a real-time reverse-transcription-polymerase chain reaction method with improved sensitivity.
    Barbero G, Destefanis P, Procida S, Mandili G, Ulliers D, Ceruti C, Fiori C, Maule MM, Fontana D, Giribaldi G, Turrini F.
    BJU Int; 2008 Dec 21; 102(11):1566-72. PubMed ID: 18549428
    [Abstract] [Full Text] [Related]

  • 8. [Differential diagnostic value of prostate-specific antigen in prostatic hyperplasia].
    Maksimov VA, Kamalov AA, Karpov VK, Riaboĭ AV, Prokhorov AV.
    Urologiia; 2001 Dec 21; (2):37-40. PubMed ID: 11490716
    [Abstract] [Full Text] [Related]

  • 9. Prostatic acid phosphatase and prostate-specific antigen in prostate cancer.
    Kuriyama M, Loor R, Wang MC, Lee C, Killian CS, Papsidero LD, Inaji H, Nishiura T, Slack NH, Murphy GP, Chu TM.
    Int Adv Surg Oncol; 1982 Dec 21; 5():29-49. PubMed ID: 6178696
    [No Abstract] [Full Text] [Related]

  • 10. [Significance of an immunoenzyme assay of the prostate-specific acid phosphatase (PAP) (E.C.3.1.3.2.) in prostatic carcinoma. Methods and initial clinical results].
    Bauer HW, Schmiedt E.
    Urologe A; 1983 Sep 21; 22 Suppl():367-71. PubMed ID: 6195796
    [Abstract] [Full Text] [Related]

  • 11. [Prostate-specific antigen and prostatic cancer].
    Otnes B, Tveter KJ.
    Tidsskr Nor Laegeforen; 1994 Mar 10; 114(7):829. PubMed ID: 7516585
    [No Abstract] [Full Text] [Related]

  • 12. [Behavior of prostate-specific antigen (PSA) in prostate tissue: correlation with prostatic acid phosphatase (PAP)].
    Morote Robles J, Segura RM, De Torres JA, Soler Roselló A.
    Actas Urol Esp; 1987 Mar 10; 11(2):180-3. PubMed ID: 2441576
    [No Abstract] [Full Text] [Related]

  • 13. Prostatic cancer and BPH.
    Brown SA.
    Postgrad Med; 1994 Jul 10; 96(1):24-5. PubMed ID: 7517542
    [No Abstract] [Full Text] [Related]

  • 14. [Summary of our clinical experience with the determination of serum prostate-specific antigen level in the first five years].
    Bánfi G, Kiss F, Kádár A, Romics I.
    Magy Onkol; 2003 Jul 10; 47(2):165-8. PubMed ID: 12975664
    [Abstract] [Full Text] [Related]

  • 15. [Experience with prostate-specific antigen in patients with prostatic cancer].
    Romics I, Bach D.
    Orv Hetil; 1989 Dec 24; 130(52):2797-800. PubMed ID: 2481833
    [Abstract] [Full Text] [Related]

  • 16. [Clinical study of tumor markers in prostatic carcinoma--an investigation on the simultaneous measurement of prostatic acid phosphatase (PAP), prostatic antigen (PA) and gamma-seminoprotein (gamma-Sm)].
    Tsukamoto T, Kumamoto Y, Yamazaki K, Umehara T, Miyao N, Ohmura K, Iwazawa M.
    Hinyokika Kiyo; 1988 Jun 24; 34(6):987-95. PubMed ID: 2464917
    [Abstract] [Full Text] [Related]

  • 17. Critical-laboratoristic correlation of the diagnostic importance of prostate specific antigen compared with prostatic acid phosphatase and carcinoembryonic antigen in the prostatic cancer.
    Milani M, Tacconi R, Marsili G, Trognoni A, Centioni G, Leoni T, Fumarola A.
    Quad Sclavo Diagn; 1986 Dec 24; 22(4):428-32. PubMed ID: 2445000
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Evaluation of plasma interleukin-8 concentration in patients with prostate cancer and benign prostate hyperplasia.
    Dehghani M, Mostafavi-Pour Z, Lotfi M, Shakeri S.
    Iran J Immunol; 2009 Jun 24; 6(2):92-8. PubMed ID: 19561378
    [Abstract] [Full Text] [Related]

  • 20. The role of prostate specific membrane antigen and pepsinogen C tissue expression as an adjunctive method to prostate cancer diagnosis.
    Antunes AA, Leite KR, Sousa-Canavez JM, Camara-Lopes LH, Srougi M.
    J Urol; 2009 Feb 24; 181(2):594-600. PubMed ID: 19084862
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 24.